# PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT

> **NCT05609201** · — · ENROLLING_BY_INVITATION · sponsor: **University of Exeter** · enrollment: 54 (estimated)

## Conditions studied

- Interstitial Lung Disease

## Interventions

- **DIAGNOSTIC_TEST:** HRCT Thorax
- **DEVICE:** Glycocheck Endothelial Glycocalyx Assessment
- **DIAGNOSTIC_TEST:** Blood biomarkers
- **DIAGNOSTIC_TEST:** Peripheral leucocyte telomere length
- **DIAGNOSTIC_TEST:** Pulmonary function testing
- **DIAGNOSTIC_TEST:** Patient reported outcome measures

## Key facts

- **NCT ID:** NCT05609201
- **Lead sponsor:** University of Exeter
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-06-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-05-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05609201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05609201, "PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05609201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*